USPTO serial 79324697
STYLONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 13, 2022
- Examiner
- SCHLEGELMILCH, JONATHON A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with STYLONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle P. Ciotola
Michelle P. Ciotola Cantor Colburn LLP20 Church StreetFloor 22Hartford, CT 06103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Machines for testing and evaluating the compressibility of pharmaceutical ingredients for the production of pharmaceutical products in the form of tablets; Scientific equipment, namely, machines for the compressing of small amounts of tablets with pharmaceutically active and inactive ingredients pre-dosed in the form of tablets; Scientific equipment, namely, machines for compressing small amounts of tablets with pharmaceutically active and inactive ingredients pre-dosed in the form of tablets for facilitating pharmaceutical research and development; computer controls for the operation of machines for the production of pharmaceutical products in the form of tablets; Downloadable computer software for the production of pharmaceutical tablets; Downloadable computer software for analyzing pharmaceutical products; Downloadable computer software for manufacturing machines for pharmaceutical products, in the nature of pharmaceutical tablets; Downloadable computer software for automation of machines, and for manufacturing pharmaceutical products; Downloadable computer software for analysis, testing, and control of machines used for manufacturing pharmaceutical products and for manufacturing tablets for the pharmaceutical industry | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 31, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 31, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 13, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 13, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 13, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 27, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 27, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 27, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 7, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 7, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 7, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 18, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 16, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 1, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 1, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 1, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 1, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 1, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 13, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 13, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 12, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 11, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 29, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 8, 2021 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |